Abstract Search

10.2. Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus

A Verma , R Rajput , S Verma , VKB Balania , B Jangra

Diabetes Metab Syndr. 2020;14(5):12131216. doi: 10.1016/j.dsx.2020.07.016In this small cross-sectional study on 52 pediactric patients with T1D, a structured questionnaire was administered on follow up within 15 days after lockdown during the COVID-19 pandemic. Of these 52 patients, 36.5% had hyperglycemic and 15.3% had hypoglycemic episodes. Insulin dose was missed in 26.9%, gluco...

0 shares

ey0018.11-1 | The COVID 19 pandemic and obesity | ESPEYB18

11.1. Characteristics of hospitalized children with SARS-CoV-2 in the New York city metropolitan area

S Verma , R Lumba , HM Dapul , G Gold-von Simson , CK Phoon , JL Lighter , JS Farkas , A Vinci , A Noor , VN Raabe , D Rhee , M Rigaud , PV Mally , TM Randis , B Dreyer , AJ Ratner , CS Manno , A Chopra

Hosp Pediatr. 2021 Jan;11(1):71–78. 10.1542/hpeds.2020-001917. https://pubmed.ncbi.nlm.nih.gov/33033078/In a cohort of 82 children (021 years) who were hospitalised for severe SARS-CoV-2 associated respiratory illness, obesity was the strongest risk factor for the outcome of critical care. Already during the first COVID-19 wave...

0 shares

ESPE Yearbook of Paediatric Endocrinology

10.2. Impact of lockdown in COVID-19 on glycemic control in patients with type 1 diabetes mellitus

11.1. Characteristics of hospitalized children with SARS-CoV-2 in the New York city metropolitan area

BiosciAbstracts